Our mission at The Chart Report is to highlight ideas from the best traders and technicians on social media.
Now, we’re taking this concept one step further and tapping into the madness of the crowd.
That’s why we created The Buzz!
Our mission at The Buzz is simple: to identify and profit from the most-talked-about stocks on the market today.
But isn’t the crowd always wrong?
The grandfather of contrarian investing, Humphrey B. Neil once said;
“The public is often right during the trends, but wrong at both ends.”
We agree with Humphrey, which is why we’ll be focusing on catching the meat of these trends, with both long and short ideas.
The Buzz uses proprietary social media data from our partners at Likefolio.
Every week, we compile a list of stocks that are experiencing the most momentum in terms of investor interest. Let’s take a look at which stocks are buzzing this week!
This table shows the rate of change in weekly mentions relative to a longer-term average of mention history. In less technical terms, this list shows us the most popular stocks on social media last week.
This Week’s Overview:
This week’s list of trending tickers was much more diverse HealthCare Technology was a small theme that stood out to me this week. Tickers like $VCEL, $CRVL World Wide Entertainment (WWE) and Endeavor Group (EDR) have been in the spotlight lately on news of a merger between the two. However, we want to avoid stocks with potential M&A news, in order to reduce the risk of gaps, whipsaws, and other messy price action.
There were a lot of attractive technical setups on this week’s list. We outlined a few of our favorites below.
Article Sales Message
Trade ideas every single week.
Exclusive video commentary breaking down our hottest trade ideas.
Regular mid-week updates on the latest stocks moving the markets.
Top 10 — The most important charts on the market, delivered every weekend.
A Members-only trade ideas portfolio, updated with key levels for all positions.
First-mover access to new scans, analysis, features, and access to the analyst team.
You need to have a subscription to access this content in full.